Genetic Technologies Ltd. - notizie pubblicate 155 - letture 2.029
GENETIC TECHNOLOGIES LTD.
Cleansing Notice under section 708A of the Corporations Act 2001 (Cth) - Form 6-K
Cleansing notice under section 708a of the corporations act 2001 (cth) on 19 april 2024 genetic technologies limited acn 009 212 328 (asx: gtg; nasdaq: gene) (the company) announce ...
GENETIC TECHNOLOGIES LTD.
Appendix 2A - Application for quotation of securities - Form 6-K
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer genetic technologies ...
GENETIC TECHNOLOGIES LTD.
Genetic Technologies Announces $2 Million Registered Direct Offering - Form 6-K
Genetic technologies announces $2 million registered direct offering melbourne , australia, april 19, 2024 (globe newswire) - genetic technologies limited (asx:gtg; nasdaq:gene, &q ...
GENETIC TECHNOLOGIES LTD.
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes - Form 6-K
New precision oncology tests to drive personalised therapies and improved treatment outcomes melbourne, australia, april 17, 2024 genetic technologies limited (asx: gtg; nasdaq: ge ...
GENETIC TECHNOLOGIES LTD.
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch “Know Your Risk” - Form 6-K
Event - empowering women through knowledge; humanise health & genetype launch "know your risk". melbourne, australia, april 8, 2024: genetic technologies limited (asx ...
GENETIC TECHNOLOGIES LTD.
GTG Secures Short Term Loan Facility with Radium Capital - Form 6-K
Gtg secures short term loan facility with radium capital melbourne, australia, 26 march 2024: genetic technologies limited (asx: gtg; nasdaq: gene, "company", "gtg&q ...
GENETIC TECHNOLOGIES LTD.
Appointment of Chief Financial Officer & Company Secretary - Form 6-K
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer genetic technologies ...
GENETIC TECHNOLOGIES LTD.
GTG to develop Worlds Most Advanced Comprehensive Risk Test - Form 6-K
Gtg to develop worlds most advanced comprehensive risk test revolutionising personalised healthcare melbourne, australia, 22 march 2024: genetic technologies limited (asx:gtg; nasd ...
GENETIC TECHNOLOGIES LTD.
Results of Extraordinary General Meeting - Form 6-K
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer genetic technologies ...
GENETIC TECHNOLOGIES LTD.
Change of Director’s Interest Notice - Form 6-K
Change of director's interest notice information or documents not available now must be given to asx as soon as available. information and documents given to asx become asx's prope ...
GENETIC TECHNOLOGIES LTD.
Explanation of results - Form 6-K
Explanation of results an explanation of the key financial elements contributing to the revenue and result above can be found in the review of operations included within the direct ...
GENETIC TECHNOLOGIES LTD.
Notice of Extraordinary Meeting - Form 6-K
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer genetic technologies ...
GENETIC TECHNOLOGIES LTD.
Board renewal and resignation of Director - Form 6-K
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer genetic technologies ...
GENETIC TECHNOLOGIES LTD.
Appendix 3H - Notification of cessation of securities - Form 6-K
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer genetic technologies ...
GENETIC TECHNOLOGIES LTD.
Launching our most comprehensive test and expanding into new global markets - Form 6-K
Launching our most comprehensive test and expanding into new global markets melbourne, australia, 31 january 2024: genetic technologies limited (asx:gtg; nasdaq:gene, "company ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti